News und Analysen

AT&T (NYSE: T) and Amazon (NASDAQ: AMZN) are both often considered stable long-term investments. AT&T is one of the largest telecom companies in the United States, and it has paid continuous

Fool.com contributor and finance professor Parkev Tatevosian compares AT&T (NYSE: T) and Deere (NYSE: DE) to determine which is the better dividend stock to buy.

*Stock prices used were the

Shares in UK-based life sciences company Abcam (NASDAQ: ABCM) were up 12.7% in the week at 11 a.m. ET. The move comes in an exciting week of news for the company, involving an unhappy founder, a

Fool.com contributor and finance professor Parkev Tatevosian compares ZIM (NYSE: ZIM) and AT&T (NYSE: T), two of the cheapest stocks he follows.

*Stock prices used were the afternoon prices of June

AT&T (NYSE: T) has long been known for its generous dividend, which investors have often been attracted to. For many, dividends seem like a guaranteed return stream and can also serve as a cash-flow

You can secure a 5% dividend yield without being too risky or aggressive. Sometimes, it's a matter of jumping on a good opportunity when it arises. A stock can fall in value for various reasons

While major wireless carriers have denied it, e-commerce and cloud computing giant Amazon (NASDAQ: AMZN) is reportedly considering adding a free or inexpensive wireless service plan onto its prime

Not for the first time this year, Horizon Technology Finance (NASDAQ: HRZN) is tapping the public markets for a fresh round of capital-raising. Investors clearly didn't consider that to be good

AT&T (NYSE: T) stock is an alluring option for income investors thanks to its robust dividend, which at current share prices yields nearly 7%. Despite this -- and the company's position as one of

With savvy stock-picking and a bit of patience, building wealth isn't as difficult as it is often made out to be. This is because quality businesses grow their revenue and profits, which makes their

Investors who watch AT&T (NYSE: T) closely know that it has spent the last two years atoning for a costly mistake. It not only strayed from its core service offerings but also overpaid to enter the

Telecom giant AT&T (NYSE: T) has a very simple story now that it's shed its ambitions to become a media conglomerate. The core business is wireless, which will grow slowly at best. The secondary

The various market indexes are all positive so far in 2023, but the rebound is not universal and there's no shortage of stocks still trading near their lows. A couple of struggling stocks that

Last year wasn't the best year for tech stocks, with many seeing drops into double-digit percentages. Luckily, 2023 has been much better. The tech-heavy Nasdaq Composite -- which tracks almost all

First Horizon (NYSE: FHN) saw its stock price rise 13.7% this week, as of Friday's opening bell, according to S&P Global Market Intelligence. The stock had been up as much as 14.7% during the week

Companies that produce generic drugs aren't known for being exciting investments, and there's little chance they'll ever expand as fast as your average tech stock or most other growth stocks. If

Telecom giant AT&T (NYSE: T) is best known today as a leading wireless provider in the United States, but it's also investing heavily in fiber internet. The company now has 7.5 million fiber

Shares of Summit Therapeutics (NASDAQ: SMMT) were down more than 13% on Tuesday. The biotech company's shares have been trending downward since it released first-quarter earnings late last week. On

Shares of Horizon Therapeutics (NASDAQ: HZNP), a rare disease specialist, were down by 17.4% on heavy volume as of 10:14 a.m. ET Tuesday morning. The drugmaker's shares are falling after news broke

Investing in high-yield dividend stocks for income is one thing, but getting a high yield at a great valuation can be a formula for long-term success when it comes to investing. In this video, we

Raise your hand if you've heard that telecom giant AT&T (NYSE: T) stock has been cheap before. Shares have been getting cheaper for years -- Ma Bell's stock price is down 40% over the past decade.

Just 14% of drugs in development (according to a 2018 study) ever make it to market, so investing in pharmaceuticals is a bit of a shot in the dark. And smaller companies that lack any approved

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are two healthcare companies aiming to produce a vaccine for the respiratory syncytial virus (RSV). In trials, their vaccine candidates have been

The biggest disappointment from AT&T's (NYSE: T) first-quarter earnings report was its dismal free cash flow.

Free cash flow is extremely important for AT&T investors, many of whom look for the

Shares of Summit Therapeutics (NASDAQ: SMMT) were up by 61.4% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock, which